keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RAD17-derived peptide, a substrate for the ataxia-telangiectasia and RAD3-related protein/kinase (ATR), facilitates the identification of ATR inhibitors.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | お問い合わせ | ¥ 13,000 |
5 mg | お問い合わせ | ¥ 56,000 |
10 mg | お問い合わせ | ¥ 98,500 |
25 mg | お問い合わせ | ¥ 215,500 |
説明 | RAD17-derived peptide, a substrate for the ataxia-telangiectasia and RAD3-related protein/kinase (ATR), facilitates the identification of ATR inhibitors. |
分子量 | 1814.10 |
分子式 | C81H132N22O25.XCF3COOH |
keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: soluble
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
RAD17-derived Peptide TFA Inhibitor inhibitor inhibit